AORTArtivion, Inc.
$21.25-48% 1Y
$21.25
$20.1052 weeks$47.63
The financials
Artivion, Inc. by the numbers
Artivion, Inc. (AORT) reported revenue of $126M in Q2 2026 (quarter ended Jun 30, 2026), up 11% from the same quarter a year earlier. That came with a gross margin of 64% and net loss of $14M. For the full year FY2025, revenue was $441M (+14% year on year) and net income $9.8M. Its largest product in Q2 2026 was Aortic Stent Grafts at $46M, 37% of the disclosed total, ahead of On X at 24%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $126M | $113M | +11% |
| Gross profit | $81M | $73M | +10% |
| Operating income | −$8.4M | $8.4M | to a loss |
| Net income | −$14M | $1.3M | to a loss |
| Diluted EPS | −$0.28 | $0.03 | to a loss |
| Product | Revenue | Share |
|---|---|---|
| Aortic Stent Grafts | $46M | 37% |
| On X | $31M | 24% |
| Preservation Services | $26M | 21% |
| Surgical Sealants | $19M | 15% |
| Other Products | $3.7M | 2.9% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $125.8M (+8.1%)
Other Products grew +35% year on yearSurgical Sealants -0.01% year on year
Segment Latestquarter on quarteryear on year
- Aortic Stent Grafts$46.4M$46.4Mquarter on quarter +4.5%year on year +16%+4.5%+16%
- On X$30.5M$30.5Mquarter on quarter +18%year on year +19%+18%+19%
- Preservation Services$25.9M$25.9Mquarter on quarter +3.8%year on year +1.3%+3.8%+1.3%
- Surgical Sealants$19.3M$19.3Mquarter on quarter +2.6%year on year -0.01%+2.6%-0.01%
- Other Products$3.7M$3.7Mquarter on quarter +62%year on year +35%+62%+35%